In addition, the overexpression of proinflammatory cytokines may inhibit the secretion of adiponectin, which results in further reduction in the anti-inflammatory effect of adiponectin, thereby providing the appropriate immunological environment for the onset and development of asthma. Here, ADIPOQ is linked to asthma.